Advertisement
Loading...

Direxion Daily S&P Biotech Bull 3X ETF

LABU•AMEX
Financial Services
Asset Management - Leveraged
$195.30
$3.64(1.90%)
U.S. Market opens in 28h 56m
Advertisement

Direxion Daily S&P Biotech Bull 3X ETF (LABU) Stock Overview

Explore Direxion Daily S&P Biotech Bull 3X ETF’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1B
P/E RatioN/A
EPS (TTM)N/A
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$125.77
3 Months$66.36
1 Year Target$123.63

LABU Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Direxion Daily S&P Biotech Bull 3X ETF (LABU) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $123.63.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.97%
5-Day Change
8.80%
1-Month Change
16.11%
3-Month Change
13.16%
6-Month Change
17.27%
Year-to-Date (YTD) Change
22.61%
1-Year Change
267.76%
3-Year Change
61.51%
5-Year Change
-83.97%
All-Time (Max) Change
-93.76%

Contact Information

https://www.direxion.com/product/daily-sp-biotech-bull-bear-3x-etfs
1-866-476-7523
1301 Avenue of the Americas, 28th Floor, New York, NY, 10019

Company Facts

IPO DateMay 28, 2015
CountryUS
Actively Trading

Frequently Asked Questions